Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David Michael Charytan, M.D.

Title
Institution
Department
Address
Phone
Fax

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R34HL140477 (CHARYTAN, DAVID M) Mar 1, 2018 - Feb 28, 2020
    NIH/NHLBI
    Randomized trials using point of care-guided manipulation of dialysate potassium, dialysate bicarbonate, and ultrafiltration rate to prevent hemodilaysis-associated arrythmia
    Role: Principal Investigator
  2. R21DK100772 (CHARYTAN, DAVID M) Jul 21, 2014 - Jun 30, 2016
    NIH/NIDDK
    NO, myocardial fibrosis, and microvascular rarefaction in ESRD: Pilot Studies
    Role: Principal Investigator
  3. R01HL118314 (CHARYTAN, DAVID M) Jan 1, 2014 - Dec 31, 2017
    NIH/NHLBI
    Optimizing Revascularization of Coronary Artery Disease in Chronic Kidney Disease
    Role: Principal Investigator
  4. U01DK096189 (CHARYTAN, DAVID M) Aug 22, 2013 - Jun 30, 2018
    NIH/NIDDK
    Aldosterone, nitric oxide, myocardial fibrosis, and capillary loss in ESRD
    Role: Principal Investigator
  5. R21DK089368 (CHARYTAN, DAVID M) Aug 1, 2010 - Jul 31, 2013
    NIH/NIDDK
    CABG and PCI for the Treatment of CAD in Individuals with CKD
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Charytan DM, Natwick T, Solid CA, Li S, Gong T, Herzog CA. Comparative Effectiveness of Medical Therapy, Percutaneous Revascularization, and Surgical Coronary Revascularization in Cardiovascular Risk Subgroups of Patients With CKD: A Retrospective Cohort Study of Medicare Beneficiaries. Am J Kidney Dis. 2019 Jun 26. PMID: 31255335.
    Citations:    
  2. Charytan DM, Sabatine MS, Pedersen TR, Im K, Park JG, Pineda AL, Wasserman SM, Deedwania P, Olsson AG, Sever PS, Keech AC, Giugliano RP. Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial. J Am Coll Cardiol. 2019 Jun 18; 73(23):2961-2970. PMID: 31196453.
    Citations:    
  3. Mavrakanas TA, Chatzizisis YS, Gariani K, Kereiakes DJ, Gargiulo G, Helft G, Gilard M, Feres F, Costa RA, Morice MC, Georges JL, Valgimigli M, Bhatt DL, Mauri L, Charytan DM. Duration of Dual Antiplatelet Therapy in Patients with CKD and Drug-Eluting Stents: A Meta-Analysis. Clin J Am Soc Nephrol. 2019 Jun 07; 14(6):810-822. PMID: 31010936.
    Citations:    
  4. Perkovic V, Jardine MJ, Neal B, Bompoint S, Heerspink HJL, Charytan DM, Edwards R, Agarwal R, Bakris G, Bull S, Cannon CP, Capuano G, Chu PL, de Zeeuw D, Greene T, Levin A, Pollock C, Wheeler DC, Yavin Y, Zhang H, Zinman B, Meininger G, Brenner BM, Mahaffey KW. Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy. N Engl J Med. 2019 06 13; 380(24):2295-2306. PMID: 30990260.
    Citations:    
  5. Tumlin JA, Roy-Chaudhury P, Koplan BA, Costea AI, Kher V, Williamson D, Pokhariyal S, Charytan DM. Relationship between dialytic parameters and reviewer confirmed arrhythmias in hemodialysis patients in the monitoring in dialysis study. BMC Nephrol. 2019 Mar 05; 20(1):80. PMID: 30836948.
    Citations:    
  6. Charytan DM, Solomon SD, Ivanovich P, Remuzzi G, Cooper ME, McGill JB, Parving HH, Parfrey P, Singh AK, Burdmann EA, Levey AS, Eckardt KU, McMurray JJV, Weinrauch LA, Liu J, Claggett B, Lewis EF, Pfeffer MA. Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease. Diabetes Obes Metab. 2019 May; 21(5):1199-1208. PMID: 30672083.
    Citations:    Fields:    
  7. Lima EG, Charytan DM, Hueb W, de Azevedo DFC, Garzillo CL, Favarato D, Linhares Filho JPP, Martins EB, Batista DV, Rezende PC, Hueb AC, Ramires JAF, Kalil Filho R. Long-term outcomes of patients with stable coronary disease and chronic kidney dysfunction: 10-year follow-up of the Medicine, Angioplasty, or Surgery Study II Trial. Nephrol Dial Transplant. 2018 Dec 24. PMID: 30590726.
    Citations:    Fields:    
  8. Charytan DM, Himmelfarb J, Ikizler TA, Raj DS, Hsu JY, Landis JR, Anderson AH, Hung AM, Mehrotra R, Sharma S, Weiner DE, Williams M, DiCarli M, Skali H, Kimmel PL, Kliger AS, Dember LM. Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trial. Kidney Int. 2019 Apr; 95(4):973-982. PMID: 30473139.
    Citations:    Fields:    
  9. Vaduganathan M, White WB, Charytan DM, Morrow DA, Liu Y, Zannad F, Cannon CP, Bakris GL. Relation of Serum and Urine Renal Biomarkers to Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus and Recent Acute Coronary Syndromes (From the EXAMINE Trial). Am J Cardiol. 2019 Feb 01; 123(3):382-391. PMID: 30477800.
    Citations:    Fields:    
  10. Garlo KG, Bates DW, Seger DL, Fiskio JM, Charytan DM. Association of Changes in Creatinine and Potassium Levels After Initiation of Renin Angiotensin Aldosterone System Inhibitors With Emergency Department Visits, Hospitalizations, and Mortality in Individuals With Chronic Kidney Disease. JAMA Netw Open. 2018 Nov 02; 1(7):e183874. PMID: 30646338.
    Citations:    
  11. Charytan DM. Introduction: Cardiovascular Disease in Chronic Kidney Disease. Semin Nephrol. 2018 11; 38(6):541. PMID: 30413249.
    Citations:    Fields:    
  12. Charytan DM, Roy-Chaudhury P. The Authors Reply. Kidney Int. 2018 08; 94(2):430-431. PMID: 30031449.
    Citations:    Fields:    Translation:Humans
  13. Mavrakanas TA, Khattak A, Singh K, Charytan DM. Echocardiographic parameters and renal outcomes in patients with preserved renal function, and mild- moderate CKD. BMC Nephrol. 2018 07 11; 19(1):176. PMID: 29996910.
    Citations:    Fields:    
  14. Weinrauch LA, Charytan DM, D'Elia JA. End-Stage Renal Disease and Arrhythmic Death. JACC Clin Electrophysiol. 2018 Jul; 4(7):975-976. PMID: 30025702.
    Citations:    
  15. Herzog CA, Natwick T, Li S, Charytan DM. Comparative Utilization and Temporal Trends in Cardiac Stress Testing in U.S. Medicare Beneficiaries With and Without Chronic Kidney Disease. JACC Cardiovasc Imaging. 2018 Jun 08. PMID: 29909107.
    Citations:    
  16. Miller BLK, Garg P, Bronstein B, LaPointe E, Lin H, Charytan DM, Tilles AW, Parekkadan B. Extracorporeal Stromal Cell Therapy for Subjects With Dialysis-Dependent Acute Kidney Injury. Kidney Int Rep. 2018 Sep; 3(5):1119-1127. PMID: 30197978.
    Citations:    
  17. Roy-Chaudhury P, Tumlin JA, Koplan BA, Costea AI, Kher V, Williamson D, Pokhariyal S, Charytan DM. Primary outcomes of the Monitoring in Dialysis Study indicate that clinically significant arrhythmias are common in hemodialysis patients and related to dialytic cycle. Kidney Int. 2018 04; 93(4):941-951. PMID: 29395340.
    Citations: 4     Fields:    Translation:Humans
  18. Garlo KG, White WB, Bakris GL, Zannad F, Wilson CA, Kupfer S, Vaduganathan M, Morrow DA, Cannon CP, Charytan DM. Kidney Biomarkers and Decline in eGFR in Patients with Type 2 Diabetes. Clin J Am Soc Nephrol. 2018 03 07; 13(3):398-405. PMID: 29339356.
    Citations: 1     Fields:    
  19. Jardine MJ, Mahaffey KW, Neal B, Agarwal R, Bakris GL, Brenner BM, Bull S, Cannon CP, Charytan DM, de Zeeuw D, Edwards R, Greene T, Heerspink HJL, Levin A, Pollock C, Wheeler DC, Xie J, Zhang H, Zinman B, Desai M, Perkovic V. The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics. Am J Nephrol. 2017 Dec 13; 46(6):462-472. PMID: 29253846.
    Citations: 7     Fields:    
  20. Charytan DM, Skali H, Shah NR, Veeranna V, Cheezum MK, Taqueti VR, Kato T, Bibbo CR, Hainer J, Dorbala S, Blankstein R, Di Carli MF. Coronary flow reserve is predictive of the risk of cardiovascular death regardless of chronic kidney disease stage. Kidney Int. 2018 02; 93(2):501-509. PMID: 29032954.
    Citations:    Fields:    Translation:Humans
  21. Mavrakanas TA, Aurian-Blajeni DE, Charytan DM. Early versus late initiation of renal replacement therapy in patients with acute kidney injury: a meta-analysis of randomised clinical trials. Swiss Med Wkly. 2017; 147:w14507. PMID: 29039628.
    Citations: 1     Fields:    Translation:Humans
  22. Mavrakanas TA, Khattak A, Singh K, Charytan DM. Epidemiology and Natural History of the Cardiorenal Syndromes in a Cohort with Echocardiography. Clin J Am Soc Nephrol. 2017 Oct 06; 12(10):1624-1633. PMID: 28801528.
    Citations: 1     Fields:    Translation:Humans
  23. Charytan DM, Solomon SD, Ivanovich P, Remuzzi G, Cooper ME, McGill JB, Parving HH, Parfrey P, Singh AK, Burdmann EA, Levey AS, de Zeeuw D, Eckardt KU, McMurray JJV, Claggett B, Lewis EF, Pfeffer MA. ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD. Am J Kidney Dis. 2017 Oct; 70(4):522-531. PMID: 28599901.
    Citations:    Fields:    Translation:Humans
  24. Stanifer JW, Charytan DM, White J, Lokhnygina Y, Cannon CP, Roe MT, Blazing MA. Benefit of Ezetimibe Added to Simvastatin in Reduced Kidney Function. J Am Soc Nephrol. 2017 Oct; 28(10):3034-3043. PMID: 28507057.
    Citations:    Fields:    Translation:Humans
  25. Perl J, Dember LM, Bargman JM, Browne T, Charytan DM, Flythe JE, Hickson LJ, Hung AM, Jadoul M, Lee TC, Meyer KB, Moradi H, Shafi T, Teitelbaum I, Wong LP, Chan CT. The Use of a Multidimensional Measure of Dialysis Adequacy-Moving beyond Small Solute Kinetics. Clin J Am Soc Nephrol. 2017 May 08; 12(5):839-847. PMID: 28314806.
    Citations: 3     Fields:    Translation:Humans
  26. Mendu ML, Ciociolo GR, McLaughlin SR, Graham DA, Ghazinouri R, Parmar S, Grossier A, Rosen R, Laskowski KR, Riella LV, Robinson ES, Charytan DM, Bonventre JV, Greenberg JO, Waikar SS. A Decision-Making Algorithm for Initiation and Discontinuation of RRT in Severe AKI. Clin J Am Soc Nephrol. 2017 02 07; 12(2):228-236. PMID: 28119408.
    Citations: 5     Fields:    Translation:Humans
  27. Mavrakanas TA, Charytan DM. Cardiovascular complications in chronic dialysis patients. Curr Opin Nephrol Hypertens. 2016 11; 25(6):536-544. PMID: 27636771.
    Citations: 2     Fields:    Translation:Humans
  28. Charytan DM. Spironolactone in Dialysis: What's Old Is New Again. Am J Kidney Dis. 2016 10; 68(4):512-514. PMID: 27664475.
    Citations:    Fields:    Translation:Humans
  29. Khattak A, Mandel EI, Reynolds MR, Charytan DM. Percutaneous Coronary Intervention Versus Optimal Medical Therapy for Stable Angina in Advanced CKD: A Decision Analysis. Am J Kidney Dis. 2017 Mar; 69(3):350-357. PMID: 27646423.
    Citations:    Fields:    Translation:Humans
  30. Charytan DM, Desai M, Mathur M, Stern NM, Brooks MM, Krzych LJ, Schuler GC, Kaehler J, Rodriguez-Granillo AM, Hueb W, Reeves BC, Thiele H, Rodriguez AE, Buszman PP, Buszman PE, Maurer R, Winkelmayer WC. Reduced risk of myocardial infarct and revascularization following coronary artery bypass grafting compared with percutaneous coronary intervention in patients with chronic kidney disease. Kidney Int. 2016 08; 90(2):411-421. PMID: 27259368.
    Citations:    Fields:    Translation:Humans
  31. Charytan DM, Foley R, McCullough PA, Rogers JD, Zimetbaum P, Herzog CA, Tumlin JA. Arrhythmia and Sudden Death in Hemodialysis Patients: Protocol and Baseline Characteristics of the Monitoring in Dialysis Study. Clin J Am Soc Nephrol. 2016 Apr 07; 11(4):721-34. PMID: 26763255.
    Citations: 7     Fields:    Translation:Humans
  32. Shah NR, Charytan DM, Murthy VL, Skali Lami H, Veeranna V, Cheezum MK, Taqueti VR, Kato T, Foster CR, Hainer J, Gaber M, Klein J, Dorbala S, Blankstein R, Di Carli MF. Prognostic Value of Coronary Flow Reserve in Patients with Dialysis-Dependent ESRD. J Am Soc Nephrol. 2016 06; 27(6):1823-9. PMID: 26459635.
    Citations: 10     Fields:    Translation:Humans
  33. Charytan DM, Cinelli A, Zeisberg EM. Association of circulating angiogenesis inhibitors and asymmetric dimethyl arginine with coronary plaque burden. Fibrogenesis Tissue Repair. 2015; 8:13. PMID: 26213574.
    Citations: 3     
  34. Khattak A, Charytan DM. Shades of grey: the conundrum of implantable defibrillators in individuals with advanced CKD. Clin J Am Soc Nephrol. 2015 Jul 07; 10(7):1107-9. PMID: 26111858.
    Citations:    
  35. Charytan DM, Padera RF, Helfand AM, Zeisberg EM. Association of activated vitamin D use with myocardial fibrosis and capillary supply: results of an autopsy study. Ren Fail. 2015 Jul; 37(6):1067-9. PMID: 25955707.
    Citations: 1     Fields:    Translation:Humans
  36. Charytan DM, Lewis EF, Desai AS, Weinrauch LA, Ivanovich P, Toto RD, Claggett B, Liu J, Hartley LH, Finn P, Singh AK, Levey AS, Pfeffer MA, McMurray JJ, Solomon SD. Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). Am J Kidney Dis. 2015 Sep; 66(3):429-40. PMID: 25935581.
    Citations: 1     Fields:    Translation:Humans
  37. Charytan DM, Fishbane S, Malyszko J, McCullough PA, Goldsmith D. Cardiorenal Syndrome and the Role of the Bone-Mineral Axis and Anemia. Am J Kidney Dis. 2015 Aug; 66(2):196-205. PMID: 25727384.
    Citations: 11     Fields:    Translation:Humans
  38. Allegretti AS, Flythe JE, Benda V, Robinson ES, Charytan DM. The effect of bicarbonate administration via continuous venovenous hemofiltration on acid-base parameters in ventilated patients. Biomed Res Int. 2015; 2015:901590. PMID: 25648653.
    Citations: 1     Fields:    Translation:Humans
  39. Charytan DM, Pai AB, Chan CT, Coyne DW, Hung AM, Kovesdy CP, Fishbane S. Considerations and challenges in defining optimal iron utilization in hemodialysis. J Am Soc Nephrol. 2015 Jun; 26(6):1238-47. PMID: 25542967.
    Citations: 17     Fields:    Translation:HumansAnimals
  40. Charytan D. Is left ventricular hypertrophy a modifiable risk factor in end-stage renal disease. Curr Opin Nephrol Hypertens. 2014 Nov; 23(6):578-85. PMID: 25295959.
    Citations: 5     Fields:    Translation:Humans
  41. Charytan DM, Padera R, Helfand AM, Zeisberg M, Xu X, Liu X, Himmelfarb J, Cinelli A, Kalluri R, Zeisberg EM. Increased concentration of circulating angiogenesis and nitric oxide inhibitors induces endothelial to mesenchymal transition and myocardial fibrosis in patients with chronic kidney disease. Int J Cardiol. 2014 Sep; 176(1):99-109. PMID: 25049013.
    Citations: 13     Fields:    Translation:HumansCells
  42. Charytan DM, Reynolds MR. Do implantable defibrillators help patients with CKD? Am J Kidney Dis. 2014 Jul; 64(1):4-6. PMID: 24954452.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  43. Gori M, Senni M, Gupta DK, Charytan DM, Kraigher-Krainer E, Pieske B, Claggett B, Shah AM, Santos AB, Zile MR, Voors AA, McMurray JJ, Packer M, Bransford T, Lefkowitz M, Solomon SD. Association between renal function and cardiovascular structure and function in heart failure with preserved ejection fraction. Eur Heart J. 2014 Dec 21; 35(48):3442-51. PMID: 24980489.
    Citations: 13     Fields:    Translation:HumansCTClinical Trials
  44. Charytan DM. How is the heart best protected in chronic dialysis patients?: Between Scylla and Charybdis: what is the appropriate role for percutaneous coronary revascularization and coronary artery bypass grafting in patients on dialysis? Semin Dial. 2014 Jul-Aug; 27(4):325-8. PMID: 24438072.
    Citations: 1     Fields:    Translation:Humans
  45. Vardi M, Yeh RW, Herzog CA, Winkelmayer WC, Setoguchi S, Charytan DM. Strategies for postmarketing surveillance of drugs and devices in patients with ESRD undergoing dialysis. Clin J Am Soc Nephrol. 2013 Dec; 8(12):2213-20. PMID: 23970129.
    Citations:    Fields:    Translation:Humans
  46. Charytan DM, Li S, Liu J, Qiu Y, Herzog CA. Risks of death and graft failure after surgical versus percutaneous coronary revascularization in renal transplant patients. J Am Heart Assoc. 2013 Feb 12; 2(1):e003558. PMID: 23525428.
    Citations: 2     Fields:    Translation:Humans
  47. LeBleu VS, Teng Y, O'Connell JT, Charytan D, Müller GA, Müller CA, Sugimoto H, Kalluri R. Identification of human epididymis protein-4 as a fibroblast-derived mediator of fibrosis. Nat Med. 2013 Feb; 19(2):227-31. PMID: 23353556.
    Citations: 31     Fields:    Translation:HumansAnimalsCells
  48. Murthy VL, Naya M, Foster CR, Hainer J, Gaber M, Dorbala S, Charytan DM, Blankstein R, Di Carli MF. Coronary vascular dysfunction and prognosis in patients with chronic kidney disease. JACC Cardiovasc Imaging. 2012 Oct; 5(10):1025-34. PMID: 23058070.
    Citations: 24     Fields:    Translation:Humans
  49. Charytan DM, Li S, Liu J, Herzog CA. Risks of death and end-stage renal disease after surgical compared with percutaneous coronary revascularization in elderly patients with chronic kidney disease. Circulation. 2012 Sep 11; 126(11 Suppl 1):S164-9. PMID: 22965978.
    Citations: 12     Fields:    Translation:Humans
  50. Charytan DM, Garg P, Varma M, Garshick MS, Jeon C, Mauri L. Angiographic characteristics of coronary arterial segments progressing to myocardial infarction in patients with and without chronic kidney disease. Clin Exp Nephrol. 2013 Apr; 17(2):232-9. PMID: 22926696.
    Citations:    Fields:    Translation:Humans
  51. Charytan DM, Forman JP. You are what you eat: dietary salt intake and renin-angiotensin blockade in diabetic nephropathy. Kidney Int. 2012 Aug; 82(3):257-9. PMID: 22791321.
    Citations: 1     Fields:    Translation:Humans
  52. Charytan DM, Stern NM, Mauri L. CKD and coronary collateral supply in individuals undergoing coronary angiography after myocardial infarction. Clin J Am Soc Nephrol. 2012 Jul; 7(7):1079-86. PMID: 22516292.
    Citations: 1     Fields:    Translation:Humans
  53. Charytan DM, Helfand AM, MacDonald BA, Cinelli A, Kalluri R, Zeisberg EM. Circulating endoglin concentration is not elevated in chronic kidney disease. PLoS One. 2011; 6(8):e23718. PMID: 21886815.
    Citations: 1     Fields:    Translation:Humans
  54. Di Carli MF, Charytan D, McMahon GT, Ganz P, Dorbala S, Schelbert HR. Coronary circulatory function in patients with the metabolic syndrome. J Nucl Med. 2011 Sep; 52(9):1369-77. PMID: 21849399.
    Citations: 14     Fields:    Translation:HumansCTClinical Trials
  55. Herzog CA, Asinger RW, Berger AK, Charytan DM, Díez J, Hart RG, Eckardt KU, Kasiske BL, McCullough PA, Passman RS, DeLoach SS, Pun PH, Ritz E. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2011 Sep; 80(6):572-86. PMID: 21750584.
    Citations: 138     Fields:    Translation:Humans
  56. Charytan DM, Patrick AR, Liu J, Setoguchi S, Herzog CA, Brookhart MA, Winkelmayer WC. Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States. Am J Kidney Dis. 2011 Sep; 58(3):409-17. PMID: 21664735.
    Citations: 23     Fields:    Translation:HumansPHPublic Health
  57. Charytan DM. Albuminuria and cardiovascular risk: time for a new direction? Clin J Am Soc Nephrol. 2011 Jun; 6(6):1235-7. PMID: 21597027.
    Citations:    Fields:    Translation:Humans
  58. Dounaevskaia V, Yan AT, Charytan D, DiMeglio L, Leong-Poi H, Al-Hesayen A, Goldstein MB, Wald R. The management of left ventricular systolic dysfunction in patients with advanced chronic kidney disease. J Nephrol. 2011 Jan-Feb; 24(1):41-9. PMID: 20349421.
    Citations:    Fields:    Translation:Humans
  59. Charytan DM, Varma MR, Silbaugh TS, Lovett AF, Normand SL, Mauri L. Long-term clinical outcomes following drug-eluting or bare-metal stent placement in patients with severely reduced GFR: Results of the Massachusetts Data Analysis Center (Mass-DAC) State Registry. Am J Kidney Dis. 2011 Feb; 57(2):202-11. PMID: 21186075.
    Citations: 5     Fields:    Translation:Humans
  60. Garg P, Charytan DM, Novack L, Cutlip DE, Popma JJ, Moses J, Leon MB, Schofer J, Breithardt G, Schampaert E, Mauri L. Impact of moderate renal insufficiency on restenosis and adverse clinical events after sirolimus-eluting and bare metal stent implantation (from the SIRIUS trials). Am J Cardiol. 2010 Nov 15; 106(10):1436-42. PMID: 21059433.
    Citations: 5     Fields:    Translation:Humans
  61. Charytan DM, Shelbert HR, Di Carli MF. Coronary microvascular function in early chronic kidney disease. Circ Cardiovasc Imaging. 2010 Nov; 3(6):663-71. PMID: 20851872.
    Citations: 6     Fields:    Translation:Humans
  62. Moslehi J, Minamishima YA, Shi J, Neuberg D, Charytan DM, Padera RF, Signoretti S, Liao R, Kaelin WG. Loss of hypoxia-inducible factor prolyl hydroxylase activity in cardiomyocytes phenocopies ischemic cardiomyopathy. Circulation. 2010 Sep 07; 122(10):1004-16. PMID: 20733101.
    Citations: 36     Fields:    Translation:AnimalsCells
  63. Charytan DM, Yang SS, McGurk S, Rawn J. Long and short-term outcomes following coronary artery bypass grafting in patients with and without chronic kidney disease. Nephrol Dial Transplant. 2010 Nov; 25(11):3654-63. PMID: 20551089.
    Citations: 6     Fields:    Translation:Humans
  64. Patel T, Charytan DM. Cardiovascular complications in diabetic kidney disease. Semin Dial. 2010 Mar-Apr; 23(2):169-77. PMID: 20210914.
    Citations: 4     Fields:    Translation:Humans
  65. Charytan DM, Wallentin L, Lagerqvist B, Spacek R, De Winter RJ, Stern NM, Braunwald E, Cannon CP, Choudhry NK. Early angiography in patients with chronic kidney disease: a collaborative systematic review. Clin J Am Soc Nephrol. 2009 Jun; 4(6):1032-43. PMID: 19423566.
    Citations: 14     Fields:    Translation:Humans
  66. Patel TV, Rennke HG, Sloan JM, DeAngelo DJ, Charytan DM. A forgotten cause of kidney injury in chronic myelomonocytic leukemia. Am J Kidney Dis. 2009 Jul; 54(1):159-64. PMID: 19185401.
    Citations: 4     Fields:    Translation:Humans
  67. Charytan DM, Kuntz RE, Garshick M, Candia S, Khan MF, Mauri L. Location of acute coronary artery thromboses in patients with and without chronic kidney disease. Kidney Int. 2009 Jan; 75(1):80-7. PMID: 18818684.
    Citations: 2     Fields:    Translation:Humans
  68. Surana SP, Riella LV, Keithi-Reddy SR, Charytan DM, Singh AK. Acute coronary syndrome in ESRD patients. Kidney Int. 2009 Mar; 75(5):558-62. PMID: 18509314.
    Citations: 3     Fields:    Translation:Humans
  69. Charytan, D. Home Hemodialysis. Nephrology Rounds (Joseph Bonventre, Barry Brenner Eds,). 2008; 6(3):1-6.
  70. Charytan DM, Kuntz RE, Garshick M, Candida S, Khan F and Mauri L. Differential spatial distribution of acute coronary artery thromboses in patients with and without chronic kidney disease. American Society of Nephrology. 2007.
  71. Charytan DM, Albrich WC, Brown RS. The case: a pregnant woman with hyponatremia. Kidney Int. 2007 Nov; 72(9):1167-9. PMID: 17943160.
    Citations: 1     Fields:    Translation:Humans
  72. Charytan D, Forman JP, Cutlip DE. Risk of target lesion revascularization after coronary stenting in patients with and without chronic kidney disease. Nephrol Dial Transplant. 2007 Sep; 22(9):2578-85. PMID: 17517798.
    Citations:    Fields:    Translation:Humans
  73. Charytan DM, Setoguchi S, Solomon DH, Avorn J, Winkelmayer WC. Clinical presentation of myocardial infarction contributes to lower use of coronary angiography in patients with chronic kidney disease. Kidney Int. 2007 May; 71(9):938-45. PMID: 17342183.
    Citations: 6     Fields:    Translation:Humans
  74. Charytan D, Kuntz RE, Mauri L, DeFilippi C. Distribution of coronary artery disease and relation to mortality in asymptomatic hemodialysis patients. Am J Kidney Dis. 2007 Mar; 49(3):409-16. PMID: 17336702.
    Citations: 25     Fields:    Translation:Humans
  75. Charytan DM, Kuntz RE. Risks of coronary artery bypass surgery in dialysis-dependent patients--analysis of the 2001 National Inpatient Sample. Nephrol Dial Transplant. 2007 Jun; 22(6):1665-71. PMID: 17299001.
    Citations: 9     Fields:    Translation:Humans
  76. Charytan DM, Kuntz RE, Chhabra A, Cutlip DE. Relationship of chronic kidney disease to cardiovascular death and myocardial infarction following coronary stenting. J Nephrol. 2006 Nov-Dec; 19(6):764-70. PMID: 17173250.
    Citations:    Fields:    Translation:Humans
  77. Wali RK, Cooper C, Iyengar M, Beck G, Berl T, Charytan D, Chonchol M, Henrich W, Himmelfarb J, Lukas M, Cheung AK., KDRC. . Efficacy of Carvedilol on heart failure (HF) in chronic kidney disease (CKD). American Society of Nephrology, San Diego, CA,. 2006.
  78. Charytan D, Kuntz RE. The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease. Kidney Int. 2006 Dec; 70(11):2021-30. PMID: 17051142.
    Citations: 35     Fields:    Translation:Humans
  79. Charytan DM, Marulkar S. Relationship of aortic atherosclerosis to acute renal failure following cardiac surgery. J Nephrol. 2006 Sep-Oct; 19(5):628-33. PMID: 17136692.
    Citations:    Fields:    Translation:Humans
  80. Charytan D, Mauri L, Agarwal A, Servoss S, Scirica B, Kuntz RE. The use of invasive cardiac procedures after acute myocardial infarction in long-term dialysis patients. Am Heart J. 2006 Sep; 152(3):558-64. PMID: 16923431.
    Citations: 12     Fields:    Translation:Humans
  81. Winkelmayer WC, Charytan DM, Brookhart MA, Levin R, Solomon DH, Avorn J. Kidney function and use of recommended medications after myocardial infarction in elderly patients. Clin J Am Soc Nephrol. 2006 Jul; 1(4):796-801. PMID: 17699289.
    Citations: 8     Fields:    Translation:Humans
  82. Ahmed SB, Abi Rached JM, Singh AK, Charytan DM. A 39-year-old pregnant woman with polyuria and hypomagnesemia. Kidney Int. 2006 Mar; 69(5):938-41. PMID: 16518355.
    Citations:    Fields:    Translation:Humans
  83. Winkelmayer WC, Charytan DM, Levin R, Avorn J. Poor short-term survival and low use of cardiovascular medications in elderly dialysis patients after acute myocardial infarction. Am J Kidney Dis. 2006 Feb; 47(2):301-8. PMID: 16431259.
    Citations: 20     Fields:    Translation:Humans
  84. Charytan D,Kuntz RE, Mauri L, deFilippi C. Proximal coronary artery disease: A common and modifiable risk-factor for mortality in asymptomatic hemodialysis patients. American Society of Nephrology. 2005.
  85. Charytan D, Winkelmayer W, Avorn J. Elderly dialysis patients have poor short-term survival and how low use of cardiovascualr medications after acute myocardial infarction. American Society of Nephrology. 2005.
  86. Charytan D, MacDonald B, Sugimoto H, Pastan S, Staton G, Hennigar R, Kalluri R. An unusual case of pulmonary-renal syndrome associated with defects in type IV collagen composition and anti-glomerular basement membrane autoantibodies. Am J Kidney Dis. 2005 Apr; 45(4):743-8. PMID: 15806477.
    Citations: 2     Fields:    Translation:HumansCells
  87. Charytan D, Torre A, Khurana M, Nicastri A, Stillman IE, Kalluri R. Allograft rejection and glomerular basement membrane antibodies in Alport's syndrome. J Nephrol. 2004 May-Jun; 17(3):431-5. PMID: 15365966.
    Citations: 1     Fields:    Translation:Humans
  88. Charytan DM, Le DD, Grossman JM, Holthaus KA, Kalluri R. Antiglomerular basement membrane autoantibodies are nonpathogenic in Wegener's granulomatosis. Am J Med. 2003 Oct 01; 115(5):414-5. PMID: 14553885.
    Citations:    Fields:    Translation:Humans
  89. Charytan D, Jansen K. Severe metabolic complications from theophylline intoxication. Nephrology (Carlton). 2003 Oct; 8(5):239-42. PMID: 15012710.
    Citations: 2     Fields:    Translation:Humans
  90. Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, Kalluri R. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med. 2003 Jul; 9(7):964-8. PMID: 12808448.
    Citations: 405     Fields:    Translation:AnimalsCells
  91. Sugimoto H, Hamano Y, Charytan D, Cosgrove D, Kieran M, Sudhakar A, Kalluri R. Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem. 2003 Apr 11; 278(15):12605-8. PMID: 12538598.
    Citations: 121     Fields:    Translation:Animals
  92. Charytan D, Goldfarb DS. Indications for hospitalization of patients with hyperkalemia. Arch Intern Med. 2000 Jun 12; 160(11):1605-11. PMID: 10847253.
    Citations: 6     Fields:    Translation:Humans
  93. Charytan D. Invasive group A streptococcal infections. N Engl J Med. 1997 Feb 13; 336(7):513; author reply 514. PMID: 9019654.
    Citations:    Fields:    Translation:HumansCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Charytan's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (340)
Explore
_
Co-Authors (64)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.